Globally, more than 1 million new cases of colorectal cancer (CRC) are diagnosed each year and CRC accounts for 10% of all cancer deaths. Symptoms (i.e., hematochezia, melena, change in bowel habits, etc.) and signs (i.e., anemia, positive fecal occult blood test, etc.) of CRC can be subtle and non - specifi c, but often indicate relatively advanced - stage disease. Since prognosis is inversely associated with CRC stage, early detection of premalignant adenomas or locally - invasive cancers is a clinical priority. Therapy for invasive malignancy is multimodal and can involve surgery, chemotherapy, and radiation therapy. Although not universally applied, guidelines have been developed for post - therapeutic CRC surveillance to detect recurrent and metachronous lesions.
|Original language||English (US)|
|Title of host publication||Practical Gastroenterology and Hepatology|
|Subtitle of host publication||Small and Large Intestine and Pancreas|
|Number of pages||10|
|State||Published - Aug 31 2010|
ASJC Scopus subject areas